home / stock / lnth / lnth news


LNTH News and Press, Lantheus Holdings Inc. From 05/27/21

Stock Information

Company Name: Lantheus Holdings Inc.
Stock Symbol: LNTH
Market: NASDAQ
Website: lantheus.com

Menu

LNTH LNTH Quote LNTH Short LNTH News LNTH Articles LNTH Message Board
Get LNTH Alerts

News, Short Squeeze, Breakout and More Instantly...

LNTH - Lantheus soars on FDA approval for PET imaging agent to identify prostate cancer

Lantheus Holdings (LNTH) has climbed ~21.0% in the premarket after announcing the FDA approval for PYLARIFY in the identification of suspected metastasis or recurrence of prostate cancer.PYLARIFY is an F 18-labeled prostate-specific membrane antigen ((PSMA)) targeted posit...

LNTH - Lantheus Receives U.S. FDA Approval of PYLARIFY® (piflufolastat F 18) Injection, the First and Only Commercially Available PSMA PET Imaging Agent for Prostate Cancer

PYLARIFY will be available immediately to imaging centers in parts of the mid-Atlantic and southern regions and is expected to be broadly available throughout the U.S. by year end Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and...

LNTH - Wall Street Breakfast: The Week Ahead

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead Investors enter next week prepped for more volatility with risk assets after the cryptocurrency plunge. The negative vib...

LNTH - Seeking Alpha Catalyst Watch

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Satu...

LNTH - Lantheus Holdings Announces Presentation Featuring 18F-DCFPyL PET/CT, its PSMA-Targeted Prostate Cancer Imaging Agent at the 2021 ASCO Annual Meeting

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to find, fight and follow serious medical conditions, announced today ...

LNTH - Lantheus Holdings, Inc. (LNTH) CEO Mary Anne Heino on Q1 2021 Results - Earnings Call Transcript

Lantheus Holdings, Inc. (LNTH) Q1 2021 Results Earnings Conference Call May 04, 2021, 08:00 AM ET Company Participants Mark Kinarney - Senior Director of Investor Relations Mary Anne Heino - President and Chief Executive Officer Robert Marshall - Chief Financial Officer and Treasurer Conferen...

LNTH - Lantheus Holdings, Inc. 2021 Q1 - Results - Earnings Call Presentation

The following slide deck was published by Lantheus Holdings, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: Lantheus Holdings, Inc. 2021 Q1 - Results - Earnings Call Presentation

LNTH - Lantheus Holdings Inc (LNTH) Q1 2021 Earnings Call Transcript

Image source: The Motley Fool. Lantheus Holdings Inc (NASDAQ: LNTH) Q1 2021 Earnings Call May 4, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Lantheus Holdings Inc (LNTH) Q1 2021 Earnings Call Transcript

LNTH - Lantheus Q1 2021 Earnings Preview

Lantheus (NASDAQ:LNTH) is scheduled to announce Q1 earnings results on Tuesday, May 4th, before market open.The consensus EPS Estimate is -$0.01 and the consensus Revenue Estimate is $87.24M (-3.8% Y/Y).Over the last 2 years, LNTH has beaten EPS estimates 100% of the time and has beaten ...

LNTH - Notable earnings before Tuesday's open

[[AME]], [[APO]], [[ARCB]], [[ARNC]], [[ATC]], [[BEN]], [[BEP]], [[BERY]], [[BG]], [[BHC]], [[BR]], [[CMI]], [[COP]], [[CQP]], [[CRL]], [[CRSR]], [[CTLT]], [[CVLT]], [[CVS]], [[CWH]], [[D]], [[DD]], [[DEA]], [[ETN]], [[ETRN]], [[EXPD]], [[FI]], [[FSS]], [[GCP]], [[GPN]], [[HEP]], [[HSC]], [[H...

Previous 10 Next 10